Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
orvepitant
Placebo
Locations
32
United States
GSK Investigational Site
Phoenix, Arizona, United States
GSK Investigational Site
Little Rock, Arkansas, United States
GSK Investigational Site
Orange, California, United States
GSK Investigational Site
Denver, Colorado, United States
GSK Investigational Site
Norwich, Connecticut, United States
GSK Investigational Site
Jacksonville, Florida, United States
Start Date
March 11, 2009
Primary Completion Date
June 21, 2010
Completion Date
June 21, 2010
Last Updated
October 13, 2017
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT06878859
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions